Patent · US Active

Tuberculosis antigen cassettes

US11638749B2 · kind B2 · utility

0Cited by
31References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 15, 2018
Grant dateMay 2, 2023
Priority date
Expiry dateOct 15, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.